Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ºñ¸¸ÇÑ ¼ºÀÎ ³²ÀÚ¿¡¼­ Ç÷Áß ·¾Æ¾°ú ºñ¾ËÄڿüº Áö¹æ°£°úÀÇ °ü°è Relationship between blood leptin and non-alcoholic fatty liver in obese male adolescent

´ëÇѳ»°úÇÐȸÁö 2001³â 61±Ç 6È£ p.634 ~ 640
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÀº»ó/Eun Sang Lee À̵·Çà/±è½Â¿¬/±èÁø¿µ/±èÈ­¼÷/ÀÌÈÆÀç/ÃÖ¿ø/±è¹ü¼ö/±èÇü±æ/±è¿µ¼ö/Don Haeng Lee/Seung Youn Kim/Jin Young Kim/Wha Sook Kim/Hoon Jae Lee/Won Choi/Pum Soo Kim/Hyung Gil Kim/Young Soo Kim

Abstract

¸ñÀû: ºñ¾ËÄڿüº Áö¹æ°£À̳ª Áö¹æ°£¿°Àº ¾ËÄÚ¿ÃÀ̳ª °£¿° ¹ÙÀÌ·¯½º¿¡ ÀÇÇÏÁö ¾Ê°í Áö¹æ»êÀÌ Áß¼ºÁö¹æ (triglyceride)ÀÇ ÇüÅ·Π°£ÀÇ ½ÇÁú¼¼Æ÷³»¿¡ ÃàÀûµÈ °æ¿ì·Î °¡Àå ÈçÇÑ ¿øÀÎÀ¸·Î½á ºñ¸¸ÀÌ ÀÖÀ¸¸ç ±× ¹Û¿¡ ´ç´¢º´À̳ª °íÁöÇ÷Áõ µîÀÌ À§ÇèÀÎÀÚ·Î ¾Ë·ÁÁ®
ÀÖ´Ù.
ÃÖ±Ù¿¡ Áö¹æ¼¼Æ÷¿¡¼­ »ý¼ºµÇ´Â °ÍÀ¸·Î ¾Ë·ÁÁø ·¾Æ¾ (leptin)Àº üÁö¹æÀ̳ª üÁú·®Áö¼ö (body mass index)¿¡ °ü°è¾øÀÌ °íÀν¶¸°Ç÷Áõ°ú À¯ÀÇÇÑ ¾çÀÇ »ó°ü°ü°è¸¦ ³ªÅ¸³»´Â °ÍÀ¸·Î º¸°íµÇ¾úÀ¸¸ç, °íÀν¶¸°Ç÷ÁõÀº °íÁß¼ºÁö¹æÇ÷ÁõÀ̳ª ºñ¾ËÄڿüº Áö¹æ°£°ú ¹ÐÁ¢ÇÑ °ü°è¸¦
º¸ÀÌ´Â
°ÍÀ¸·Î ¹àÇôÁ® ·¾Æ¾ÀÌ ºñ¾ËÄڿüº Áö¹æ°£ÀÇ ¿øÀÎÀ̳ª À¯¹ß¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °¡´É¼ºÀ» ½Ã»çÇÏ°í ÀÖ´Ù. µû¶ó¼­ º» ¿¬±¸¿¡¼­´Â ¼ºÀÎ ³²ÀÚ¿¡¼­ Ç÷Áß ·¾Æ¾À» ÃøÁ¤ÇÏ¿© ºñ¾ËÄڿüº Áö¹æ°£°ú »ó°ü°ü°è°¡ ÀÖ´ÂÁö¸¦ ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù. ¹æ¹ý: ¿ì¼± üÁú·®Áö¼ö°¡ 25
§¸/§³
ÀÌ»óÀÎ ¼ºÀÎ ³²ÀÚ ÃÑ 310¸íÀ» ´ë»óÀ¸·Î ÇÏ¿© °£±â´É °Ë»ç¿Í °£ÃÊÀ½Æĸ¦ ±âÁØÀ¸·Î ´ëÁ¶±º°ú Áö¹æ°£ ȯÀÚ±ºÀ¸·Î ±¸ºÐÇÏ°í, ¿¬·É ¹× ´Ù¾çÇÑ ½Åü °Ë»çÄ¡¿Í °£±â´É °Ë»ç, Ç÷´ç, ±×¸®°í ÁöÁú°Ë»ç¿Í Àν¶¸° ¹× ·¾Æ¾À» ÃøÁ¤ÇÏ¿© °¢°¢ÀÇ Æò±Õ°ªÀ» ¾ç ±º¿¡¼­ ºñ±³ÇÏ¿´°í µÎ
±º¿¡¼­
°¢°¢ Ç÷Áß ·¾Æ¾ ³óµµ¿Í ´Ù¸¥ º¯¼öµé°úÀÇ »ó°ü°è¼ö¸¦ Á¶»çÇÏ¿´´Ù. °á°ú: ¾ç ±º¿¡¼­ °¢°¢ Ç÷Áß ·¾Æ¾ ³óµµ¿Í ´Ù¸¥ º¯¼öµé°úÀÇ »ó°ü°è¼ö¸¦ Á¶»çÇÏ¿´´Âµ¥, ȯÀÚ±º¿¡¼­ Ç÷Áß ·¾Æ¾°ú Àν¶¸° ³óµµ¸¸ÀÌ À¯ÀÇÇÑ »ó°ü°ü°è¸¦ º¸¿´´Ù. ±×¸®°í ¿¬·É, ½ÅÀå, üÁß,
üÁú·®Áö¼ö´Â ¾ç
±º°£¿¡ À¯ÀÇÇÑ Â÷À̸¦ º¸ÀÌÁö ¾Ê¾Ò°í, Ç÷´ç, ¾ËºÎ¹Î, ÃѺô¸®·çºó, ALP, ¥ã-GT, ÃÑÄÝ·¹½ºÅ׷ѵµ ¿ª½Ã ¾ç ±º°£¿¡ À¯ÀÇÇÑ Â÷À̸¦ º¸ÀÌÁö ¾Ê¾Ò´Ù. ±×·¯³ª Áß¼ºÁö¹æÀº ´ëÁ¶±º¿¡ ºñÇØ È¯ÀÚ±º¿¡¼­ À¯ÀÇÇÏ°Ô ³ô°Ô ÃøÁ¤µÇ¾ú°í, °í¹Ðµµ ÄÝ·¹½ºÅ×·ÑÀº ȯÀÚ±º¿¡¼­ À¯ÀÇÇÏ°Ô
³·¾Ò´Ù.
¶ÇÇÑ, Ç÷Áß Àν¶¸° ¹× ·¾Æ¾ ³óµµ´Â ´ëÁ¶±º¿¡ ºñÇØ È¯ÀÚ±º¿¡¼­ À¯ÀÇÇÏ°Ô ³ô°Ô ÃøÁ¤µÇ¾ú´Ù. °á·Ð: ÀÌ»óÀÇ °á°ú¿¡¼­ º¼ ¶§, ºñ·Ï ȯÀÚ±º¿¡¼­ Ç÷Áß ·¾Æ¾ ³óµµ°¡ Áõ°¡ÇÒ¼ö·Ï AST³ª ALT ¼öÄ¡°¡ Áõ°¡ÇÏÁö´Â ¾Ê¾ÒÁö¸¸, ´ëÁ¶±º°ú ȯÀÚ±º »çÀÌ¿¡ ¿¬·ÉÀ̳ª üÁú·®Áö¼ö´Â
¼­·Î
Â÷À̸¦ º¸ÀÌÁö ¾Ê´Âµ¥ ºñÇØ Ç÷Áß ·¾Æ¾ ³óµµ´Â Áö¹æ°£ ȯÀÚ±º¿¡¼­ À¯ÀÇÇÏ°Ô ³ô¾Ò´Ù. µû¶ó¼­ ·¾Æ¾ÀÌ ºñ¾ËÄڿüº Áö¹æ°£À» ÀÏÀ¸Å°´Â º´ÀÎÀ¸·Î ÀÛ¿ëÇÒ°ÍÀ¸·Î »ý°¢µÈ´Ù.

Background: The non-alcoholic fatty liver is characterised by accumylation of triglycerides within liver parenchymal cells without intake of alcohol. Leptin is produced by peripheral adipose cells and it's blood concentrations are
positively
correlated with blood insulin levels, independent of body mass index. Non-alcoholic fatty liver is associated with insulin resistance and hyperinsulinemia even in lean subjects. Therefore, we aimed to elucidate whether hyperleptinemia is
associated
with
non-alcoholic fatty liver, independent of age and obesity. Methods: The age, weight, BMI and blood laboratory data such as LFT, lipid profiles, insulin, and leptin were analyzed on 26 control subjects and 30 non-alcoholic fatty liver
subjects
with BMI above 25 §¸/§³ in male adults. Results: There was no significant difference in their age, height, weight, and BMI between normal control group and non-alcoholic fatty liver group. But, blood triglyceride, leptin, and insulin level
of
patients with non-alcoholic fatty liver were significantly higher than those of normal control group. Conclusion: Blood leptin levels of non-alcoholic fatty liver group were significantly higher than that of control group. Thus, high
circulating
leptin concentrations may play a role in the pathogenesis of non-alcoholic fatty liver, regardless of age and obesity.

Å°¿öµå

Leptin; Insulin; Liver; Fatty; Triglycerides;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS